HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody

被引：0

作者：

Yoshikawa, A. ^{[1
]}

Ito, K. ^{[2
]}

Yuki, S. ^{[3
]}

Kawamoto, Y. ^{[2
]}

Saito, R. ^{[2
]}

Yamamura, T. ^{[3
]}

Yagisawa, M. ^{[4
]}

Ishiguro, A. ^{[5
]}

Muto, O. ^{[6
]}

Hatanaka, K. ^{[7
]}

Okuda, H. ^{[8
]}

Sato, A. ^{[9
]}

Sasaki, Y. ^{[10
]}

Nakamura, M. ^{[11
]}

Sasaki, T. ^{[12
]}

Kobayashi, T. ^{[13
]}

Dazai, M. ^{[14
]}

Nakatsumi, H. ^{[15
]}

Ueda, A. ^{[16
]}

Sakata, Y. ^{[17
]}

Komatsu, Y. ^{[2
]}

机构：

[1] Kushiro Rosai Hosp, Dept Med Oncol, Kushiro, Japan

[2] Hokkaido Univ Hosp, Div Canc Ctr, Sapporo, Hokkaido, Japan

[3] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan

[4] Japanese Red Cross Kitami Hosp, Dept Med Oncol, Kitami, Hokkaido, Japan

[5] Teine Keijinkai Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan

[6] Japanese Red Cross Akita Hosp, Dept Med Oncol, Akita, Japan

[7] Hakodate Municipal Hosp, Dept Gastroenterol, Hakodate, Hokkaido, Japan

[8] Keiyukai Sapporo Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan

[9] Hirosaki Univ, Grad Sch Med, Dept Med Oncol, Hirosaki, Aomori, Japan

[10] Hakodate Cent Gen Hosp, Dept Med Oncol, Hakodate, Hokkaido, Japan

[11] Sapporo City Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan

[12] Hokkaido Gastroenterol Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan

[13] Tomakomai City Hosp, Dept Gastroenterol, Tomakomai, Japan

[14] Sapporo Med Ctr NTT EC, Dept Gastroenterol, Sapporo, Hokkaido, Japan

[15] Hokkaido Med Ctr, Dept Gastroenterol, Sapporo, Hokkaido, Japan

[16] Toyama Red Cross Hosp, Dept Med Oncol, Toyama, Japan

[17] Misawa City Hosp, Misawa, Japan

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.05.134

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-79

引用

页码：S124 / S124

页数：1

共 50 条

[1] HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment
Kaneko, S.
Ito, K.
Yuki, S.
Harada, K.
Yagisawa, M.
Sawada, K.
Ishiguro, A.
Muto, O.
Hatanaka, K.
Okuda, H.
Sato, A.
Sasaki, Y.
Nakamura, M.
Sasaki, T.
Tsuji, Y.
Ando, T.
Kato, K.
Wakabayashi, T.
Kotaka, M.
Takahashi, Y.
Sakata, Y.
Komatsu, Y.
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S125 - S125
[2] HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of first-line treatment
Ito, K.
Yuki, S.
Nakano, S.
Yagisawa, M.
Sawada, K.
Ishiguro, A.
Muto, O.
Hatanaka, K.
Okuda, H.
Sato, A.
Sasaki, Y.
Nakamura, M.
Sasaki, T.
Kobayashi, T.
Dazai, M.
Nakatsumi, H.
Ueda, A.
Tateyama, M.
Sogabe, S.
Matsumoto, R.
Sakata, Y.
Komatsu, Y.
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S108 - S108
[3] HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer - Impact of single-heterozygous UGT1A1 on the clinical outcomes
Yuki, S.
Ito, K.
Harada, K.
Kawamoto, Y.
Yagisawa, M.
Sawada, K.
Ishiguro, A.
Muto, O.
Hatanaka, K.
Okuda, H.
Sato, A.
Sasaki, Y.
Nakamura, M.
Meguro, T.
Dazai, M.
Nakatsumi, H.
Ueda, A.
Sakamoto, N.
Sakata, Y.
Komatsu, Y.
[J]. ANNALS OF ONCOLOGY, 2022, 33 : S1449 - S1449
[4] Phase II study of irinotecan and bevacizumab plus alternate day S-1 as second-line treatment in patients with metastatic colorectal cancer.
Tanaka, Chihiro
Matsuda, Chu
Kondo, Ken
Tokunaga, Yukihiko
Takahashi, Takao
Kosugi, Chihiro
Takemoto, Hiroyoshi
Iwamoto, Shigeyoshi
Oba, Koji
Sakamoto, Junichi
Mishima, Hideyuki
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[5] Efficacy and safety of CapeIRI plus bevacizumab therapy as a second-line treatment for patients with metastatic colorectal cancer
Sunagawa, Y.
Nakayama, G.
Hattori, N.
Ezaka, K.
Uda, H.
Umeda, S.
Sato, B.
Yamada, S.
Sugimito, H.
Koike, M.
Kodera, Y.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[6] A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
Nakatsumi, Hiroshi
Komatsu, Yoshito
Harada, Kazuaki
Kawamoto, Yasuyuki
Yuki, Satoshi
Sawada, Kentaro
Ishiguro, Atsushi
Sogabe, Susumu
Ando, Takayuki
Sasaki, Yusuke
Yoshikawa, Ayumu
Nakamura, Michio
Dazai, Masayoshi
Tateyama, Miki
Muto, Osamu
Kotaka, Masahito
Sagawa, Tamotsu
Muranaka, Tetsuhito
Hatanaka, Kazuteru
Takagi, Ryo
Sakata, Yu
[J]. INTERNATIONAL JOURNAL OF CANCER, 2024,
[7] Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen
Tanioka, Hiroaki
Shimada, Ken
Tsuji, Akihito
Kochi, Mitsugu
Kim, Ho Min
Takahashi, Takao
Denda, Tadamichi
Takagane, Akinori
Watanabe, Takanori
Kotaka, Masahito
Nakamura, Masato
Sunakawa, Y. U.
Takeuchi, Masahiro
Ichikawa, Wataru
Fujii, Masashi
[J]. ANTICANCER RESEARCH, 2022, 42 (05) : 2675 - 2681
[8] A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study
Chu Matsuda
Michitaka Honda
Chihiro Tanaka
Ken Kondo
Takao Takahashi
Chihiro Kosugi
Yukihiko Tokunaga
Hiroyoshi Takemoto
Ho Min Kim
Junichi Sakamoto
Koji Oba
Hideyuki Mishima
[J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 1035 - 1041
[9] A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study
Matsuda, Chu
Honda, Michitaka
Tanaka, Chihiro
Kondo, Ken
Takahashi, Takao
Kosugi, Chihiro
Tokunaga, Yukihiko
Takemoto, Hiroyoshi
Kim, Ho Min
Sakamoto, Junichi
Oba, Koji
Mishima, Hideyuki
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1035 - 1041
[10] Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients
Mitsukuni Suenaga
Satoshi Matsusaka
Masashi Ueno
Noriko Yamamoto
Eiji Shinozaki
Nobuyuki Mizunuma
Toshiharu Yamaguchi
Kiyohiko Hatake
[J]. Surgery Today, 2011, 41 : 1067 - 1074

← 1 2 3 4 5 →